Nuance Buys New York Software Firm
SAN FRANCISCO -- Continuing to consolidate the software market for speech recognition, Nuance (NUAN) said Tuesday it acquired Commissure, a New York-based developer.
Commissure develops speech recognition and other data-capture software specifically for medical imaging labs. The deal enables Nuance to provide a fuller suite of software for the radiology market.
Friedman Billings analyst Daniel Ives estimated that Nuance paid $4 million for the company. But the deal is Nuance's sixth in 2007 and brings its total acquisition outlay to between $775 million and $800 million, Ives said in an interview. The company is using acquisitions to expand its product portfolio, rather than to buy market share.
Nuance is by far the leader in voice-recognition software, with nearly 66% of the market in 2006, according to Gartner. The company's nearest competitor, LumenVox, has 7.8%, while IBM (IBM) has 6.6% and Microsoft (MSFT) has 3.2%.Although a small transaction that should have a "negligible financial impact," the deal beefs up Nuance's healthcare product suite, Ives said in a research note Tuesday. The acquisition will enable Burlington, Mass.-based Nuance to speed its transcription process while reducing costs, "hitting a major pain point of current healthcare customers worldwide," Ives wrote. FBR makes a market in shares of Nuance. Shares of Nuance were recently down 7 cents, or 0.4%, to $19.32. The stock trades at 25 times 2008 expected EPS of 78 cents.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV